Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Cuenca-Barrales

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Life (Basel, Switzerland)|January 21, 2022
Epidermal Barrier Function and Skin Homeostasis in Atopic Dermatitis: The Impact of AgeTrinidad Montero-Vilchez, Carlos Cuenca-Barrales, Juan-Angel Rodriguez-Pozo, et al.
Dermatology (Basel, Switzerland)|April 27, 2022
Intralesional Treatments in Hidradenitis Suppurativa: A Systematic ReviewCarlos Cuenca-Barrales, Trinidad Montero-Vílchez, Manuel Sánchez-Díaz, et al.
Dermatology (Basel, Switzerland)|December 5, 2022
Patterns of Surgical Recurrence in Patients with Hidradenitis SuppurativaCarlos Cuenca-Barrales, Trinidad Montero-Vílchez, Manuel Sanchez-Diaz, et al.
Dermatology and Therapy|June 11, 2025
Oral Supplementation with a New Hyaluronic Acid Matrix Ingredient Improves Skin Brightness, Hydration, Smoothness, and Roughness: Results from a Randomized, Double-Blinded, Placebo-Controlled StudyTrinidad Montero-Vilchez, Patricia Gálvez-Martín, Raquel Sanabria-de la Torre, et al.
Contact Dermatitis|December 26, 2021
Assessment of hand hygiene strategies on skin barrier function during COVID-19 pandemic: A randomized clinical trialTrinidad Montero-Vilchez, Antonio Martinez-Lopez, Carlos Cuenca-Barrales, et al.
Dermatology and Therapy|June 19, 2024
Insights into the Window of Opportunity and Outcome Measures in Patients with Moderate to Severe Hidradenitis Suppurativa Treated with Secukinumab: A Real-World StudySofía Haselgruber, Pablo Fernández-Crehuet-Serrano, María Dolores Fernández-Ballesteros, et al.
Dermatology (Basel, Switzerland)|May 26, 2025
Implementation of a Multidisciplinary Medical-Surgical Consultation in Hidradenitis Suppurativa Improves Patient Journey and Time to SurgeryCarmen García-Moronta, Francisco Javier León-Pérez, Sofía Haselgruber, et al.
Dermatology and Therapy|March 9, 2023
Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective StudyPablo Fernandez-Crehuet, Sofía Haselgruber, Alicia Padial-Gomez, et al.
The Australasian Journal of Dermatology|June 19, 2024
Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational studyMiguel Mansilla-Polo, Martí Pons-Benavent, Pablo Fernández-Crehuet, et al.
Journal of the American Academy of Dermatology|January 23, 2021
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort studyKelsey R van Straalen, Thrasyvoulos Tzellos, Phillipe Guillem, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Life (Basel, Switzerland)|January 21, 2022
Epidermal Barrier Function and Skin Homeostasis in Atopic Dermatitis: The Impact of AgeTrinidad Montero-Vilchez, Carlos Cuenca-Barrales, Juan-Angel Rodriguez-Pozo, et al.
Dermatology (Basel, Switzerland)|April 27, 2022
Intralesional Treatments in Hidradenitis Suppurativa: A Systematic ReviewCarlos Cuenca-Barrales, Trinidad Montero-Vílchez, Manuel Sánchez-Díaz, et al.
Dermatology (Basel, Switzerland)|December 5, 2022
Patterns of Surgical Recurrence in Patients with Hidradenitis SuppurativaCarlos Cuenca-Barrales, Trinidad Montero-Vílchez, Manuel Sanchez-Diaz, et al.
Dermatology and Therapy|June 11, 2025
Oral Supplementation with a New Hyaluronic Acid Matrix Ingredient Improves Skin Brightness, Hydration, Smoothness, and Roughness: Results from a Randomized, Double-Blinded, Placebo-Controlled StudyTrinidad Montero-Vilchez, Patricia Gálvez-Martín, Raquel Sanabria-de la Torre, et al.
Contact Dermatitis|December 26, 2021
Assessment of hand hygiene strategies on skin barrier function during COVID-19 pandemic: A randomized clinical trialTrinidad Montero-Vilchez, Antonio Martinez-Lopez, Carlos Cuenca-Barrales, et al.
Dermatology and Therapy|June 19, 2024
Insights into the Window of Opportunity and Outcome Measures in Patients with Moderate to Severe Hidradenitis Suppurativa Treated with Secukinumab: A Real-World StudySofía Haselgruber, Pablo Fernández-Crehuet-Serrano, María Dolores Fernández-Ballesteros, et al.
Dermatology (Basel, Switzerland)|May 26, 2025
Implementation of a Multidisciplinary Medical-Surgical Consultation in Hidradenitis Suppurativa Improves Patient Journey and Time to SurgeryCarmen García-Moronta, Francisco Javier León-Pérez, Sofía Haselgruber, et al.
Dermatology and Therapy|March 9, 2023
Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective StudyPablo Fernandez-Crehuet, Sofía Haselgruber, Alicia Padial-Gomez, et al.
The Australasian Journal of Dermatology|June 19, 2024
Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational studyMiguel Mansilla-Polo, Martí Pons-Benavent, Pablo Fernández-Crehuet, et al.
Journal of the American Academy of Dermatology|January 23, 2021
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort studyKelsey R van Straalen, Thrasyvoulos Tzellos, Phillipe Guillem, et al.
Pageof 5